Temprian Therapeutics: developing a gene-based treatment for vitiligo

A modified protein to disrupt the autoimmune cascade that can lead to the skin-pigment condition makes the company a finalist for The Spinoff Prize. A modified protein to disrupt the autoimmune cascade that can lead to the skin-pigment condition makes the company a finalist for The Spinoff Prize.